About Stelis Biosource
Stelis Biosource is a Healthcare company based in Bengaluru (India) founded in 2012. End-to-end biopharmaceutical manufacturing solutions are provided by Stelis Biosource. Stelis Biosource has raised $125 million across 1 funding round from investors including TPG, RouteOne and Mankekar Family Office. The company has 1,425 employees. Its chief executive, as recorded, is Joe Thomas. Its focus areas include Biopharma Outsourcing, CDMO and Biologics. Its legal entity in India is Stelis Biopharma Private Limited (U24100KA2012PTC063995). Its competitors include Kemwell Biopharma and Laurus Bio; 1 of its 2 listed competitors has raised funding.
Company details
Stelis Biosource was established in 2012 in Bengaluru, India, as the CDMO division of Stelis Biopharma. Biopharmaceutical services are delivered across process development, scale-up in microbial and mammalian systems, downstream operations like chromatography and filtration, formulation for injectables, analytical methods including bioassays and stability testing, and cGMP manufacturing in certified facilities.
- Headquarters Bengaluru, India
- Employees 1,425
- SectorsHealthcare
- Website stelisbiosource.com
- Social LinkedIn
- Legal Name Stelis Biopharma Private Limited
- Date of Incorporation 16 May, 2012
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue$21.28 M (USD)325as on Mar 31, 2024
- Net Profit-$44.18 M (USD)12as on Mar 31, 2024
- EBITDA-$24.16 M (USD)34as on Mar 31, 2024
- Total Equity Funding$125M (USD)
in 1 rounds
- Latest Funding Round$125M (USD), Series C
Mar 2021
- InvestorsTPG
& 4 more
- Employee Count1,425
Associated legal entities of Stelis Biosource
Stelis Biosource operates through Stelis Biopharma Private Limited (amalgamated). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Stelis Biopharma Private Limited CIN U24100KA2012PTC063995 | Amalgamated | 16 May 2012 | Bangalore, Karnataka | 2 | View details |
Funding Insights of Stelis Biosource
Stelis Biosource has successfully raised a total of $125M through 1 strategic funding round. The most recent funding activity was a Series C round of $125 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $125M
- Total Rounds 1
- Last Round Series C — $125M
- First Round $125M
(Mar 2021)
- Investors Count 5
All 1 funding rounds of Stelis Biosource with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $125M | Series C | – | TPG |
5 investors in total: 5 institutional.
Investors in Stelis Biosource
Stelis Biosource has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include TPG, RouteOne and Mankekar Family Office.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Fund of funds focused on pre-seed and seed-stage companies | 1992 | tpg.com | Fort Worth, United States | |
Single family office of Shivanand Shankar Mankekar, founder of manekar family office | mankekarfamilyoffice.tcc.mode | Mumbai, India | ||
Investment Firm | thinkinvestments.com | San Francisco, United States | ||
| gmsholdings.com | ||||
Web-based credit applications are managed for automotive dealerships. | 2002 | routeone.com | Detroit, United States |
Investor details for Stelis Biosource
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Stelis Biopharma Private Limited (Stelis Biosource)
Stelis Biopharma Private Limited is the primary company behind Stelis Biosource. The board of Stelis Biopharma Private Limited currently have 2 directors; the longest-serving is Sudhir Krishna Kanchan, appointed in 2012. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sudhir Krishna Kanchan DIN 01606191 | Director | 16 May 2012 | 14 yrs 5 mo | Stelis Biopharma Private Limited |
| Joe Thomas Mangalam DIN 00468077 | Additional Director | 06 Mar 2014 | 12 yrs 7 mo | Stelis Biopharma Private Limited |
People of Stelis Biosource
1 people are tracked at Stelis Biosource (1 in leadership); the tracked headcount is 1,425.
| Name | Role | Group |
|---|---|---|
| CEO | Leadership |
Complete people profiles for Stelis Biosource
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Stelis Biosource
2 dated milestones of Stelis Biosource across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Stelis Biosource is founded.
- Funding First funding round of $125.0M.
Competitors of Stelis Biosource
Stelis Biosource has 2 listed competitors in our database, 1 of them funded. They include Kemwell Biopharma and Laurus Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kemwellbiopharma.com | 1980 | Bengaluru, India | 298 | Integrated biologics development and manufacturing are provided as a CDMO. | ||
| laurus.bio | 2005 | Bengaluru, India | $18.89M | 6,094 | Precision fermentation services for biopharma and food are provided. |
Detailed competitors of Stelis Biosource
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Stelis Biosource (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Stelis Biosource
Complete news archive for Stelis Biosource
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stelis Biosource
Stelis Biosource was founded in 2012 and raised its 1st funding round 9 years after it was founded.
Stelis Biosource is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Joe Thomas is the CEO of Stelis Biosource, as recorded in our data.
Stelis Biosource is a funded company, having raised a total of $125M across 1 funding round to date. The company's 1st funding round was a Series C of $125M, raised on Mar 2021.
Stelis Biosource has 1,425 employees.
Annual revenue of Stelis Biosource is $21.28M as on Mar 31, 2024.
Stelis Biosource was established in 2012 in Bengaluru, India, as the CDMO division of Stelis Biopharma. Biopharmaceutical services are delivered across process development, scale-up in microbial and mammalian systems, downstream operations like chromatography and filtration, formulation for injectables, analytical methods including bioassays and stability testing, and cGMP manufacturing in certified facilities.
Stelis Biosource's top competitors include Laurus Bio and Kemwell Biopharma.
Stelis Biosource has 5 investors. Key investors include TPG, RouteOne, Mankekar Family Office, Think Investments, and GMS Holdings.
Stelis Biosource operates through Stelis Biopharma Private Limited.
The legal entities of Stelis Biosource currently have 2 directors, including Joe Thomas Mangalam, Sudhir Krishna Kanchan.